亚洲社会药学

本期目录

2018年, 第13卷, 第4期　刊出日期：2018-12-20 上一期    下一期

论文

Select

Team Structure of Higher Clinical Pharmacy Education System in the United States: A Study and Its Enlightenment Hou Xuelian, Wu Zhi’ang 2018 (4):  107-112.  摘要 ( 488 )   PDF(423KB) ( 558 )   Objective To promote the reform of team structure of clinical pharmacy education in China by drawing on the experience of the United States. Methods Team structure of higher clinical pharmacy education system in the United States, including quantitative structure and knowledge structure was studied from the two aspects of faculty and students. Results and Conclusion The characteristics of the team structure of the clinical pharmacy education system in the United States were analyzed as follows: the students in clinical pharmacy account for the absolutely larger proportion of the whole students in the school of pharmacy; there is a low student-teacher ratio in the clinical pharmacy education; knowledge structure of the faculty is reasonable; knowledge structure of the students is comprehensive. On the basis of briefly expounding the problems in the team structure of higher clinical pharmacy education in China, some strategies for promoting the reform of the team structure of clinical pharmacy education in China are put forward by drawing on the experience of the United States. 相关文章 | 计量指标

Select

Project Management of Generic Drug R&D and Registration in the United States Mao Xiaofang, Qi Xiang, Zhou Fengxiang 2018 (4):  113-123.  摘要 ( 478 )   PDF(657KB) ( 1276 )   Objective To discuss registration strategy of abbreviated new drug application (ANDA) for generic drugs in the United States from the perspective of project process and working contents of generic drug R&D and registration on the basis of project management, and to provide references for the internationalization strategy of generic drugs in China. Methods Working experience and literature review was used to analyze the content and key elements involved in the process of generic drug R&D and ANDA. Results and Conclusion Project management of generic drug from R&D to ANDA includes the working contents of each stage, such as lab R&D, scale-up R&D, technology transfer, submission for batch production, bioequivalence test and registration filling. And then periodical goals should be achieved with time scheduling and resource allocation. 相关文章 | 计量指标

Select

Current Status of Medical Treatment of Residents in Shenyang City after the 2017 New Healthcare Reform Wang Ruilin, Chen Diya, Li Zhihao, Li Wanting, Zhou Yangqian, Zhang Fang 2018 (4):  124-130.  摘要 ( 540 )   PDF(557KB) ( 425 )   Objective To propose better solutions to the problem of residents seeking medical treatment through the investigation of different individuals, and to study whether the problem of “inadequate and overly expensive medical service” has been alleviated and the existing or emerging problems after the implementation of the 2017 new healthcare reform. Methods The background and content of the 2017 new policy was studied to investigate whether the medical treatment situation was getting better. Results and Conclusion Such results are obtained: (1) Medical joint system still needs to be promoted; (2) The awareness of making an appointment with doctors and hierarchical diagnosis of the public is weak; (3) Health insurance system has to be perfected. Suggestions are for the authority raised: (1) Improving health insurance system; (2) Strengthening supervision and keeping the rules for reward and punishment; (3) Considering seriously who the “one lift and two drop” regulation applies to; (4) Making community service for the elder better; (5) Focusing on middle-aged and senior citizens. Residents should raise the awareness of hierarchical diagnosis. 相关文章 | 计量指标

Select

Analysis on Drug Information Standard in China Wang Yan, Wu Zhi’ang 2018 (4):  131-135.  摘要 ( 377 )   PDF(405KB) ( 387 )   Objective To find out how drug information standards will affect information sharing in China. Methods Four kinds of drug information standards from official sources were selected as research objects to analyze their existing problems respectively according to the government’s requirement and scope of strict drug control. Results and Conclusion There is lack of consensus among the four official sources of drug information standards, and each of them was designed to meet the needs of a specific sector. None of the standards can fully meet all needs. There is an urgent need to establish a coordination mechanism. Therefore, it is suggested that drug ontology should be set up to support information sharing. 相关文章 | 计量指标

Select

The Collaboration of Pharmacy Quality Control Circle and IndustryUniversity-Research to Promote Regional Health Wang Shuling, Li Yahui, Shi Ping 2018 (4):  136-141.  摘要 ( 479 )   PDF(599KB) ( 407 )   Objective To study the establishment of synergistic mechanism between the pharmacy quality control circle and industry-universityresearch and apply it to Shenyang or other cities to improve regional health. Methods Definition of collaboration between pharmacy quality control circle and industry-university-research, the development environment and background and the necessity of bringing the pharmacy quality control circle into the three were introduced. Meanwhile, the synergistic mechanism and application status of the industry-university-research collaboration in pharmacy was analyzed to propose relevant countermeasures and suggestions. Results and Conclusion Coordinating the pharmacy quality control circle with industry-university-research industry can contribute a lot: the application scope of the quality control circle has expanded, the number of documents has increased, and related cases and activities have grown rapidly, which provide a new concept and methods for management improvement for enterprises of pharmaceutical production, marketing and use, and effectively protect people’s health. Pharmacy quality control circle can effectively strengthen the cooperation mechanism of industry-university-research, and improve the comprehensive quality of pharmaceutical practitioners and the quality of management of drug-related departments to ensure drug safety and promote regional health. 相关文章 | 计量指标

Select

Export of Health Care Products in China: Current Status and Countermeasures Xia Xing, Liu Yue, Dong Weitian, Zhao Xiaoyu, Liu Yunfan, Dong Li 2018 (4):  142-147.  摘要 ( 572 )   PDF(444KB) ( 453 )   Objective To provide suggestions for the export of China’s health care products. Methods Literature review was applied to analyze the existing problems in the export of China’s health care products and the countermeasures were put forward. Results and Conclusion Countermeasures and suggestions for the export of health care products are of certain significance to related enterprises. 相关文章 | 计量指标